Gainers
- Salarius Pharmaceuticals (NASDAQ:SLRX) stock increased by 24.7% to $0.2 during Wednesday's after-market session. Salarius Pharmaceuticals's trading volume hit 102.4K shares by close, accounting for 17.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $11.1 million.
- Hyperfine (NASDAQ:HYPR) shares rose 22.72% to $2.7. The company's market cap stands at $189.8 million. The company's, Q1 earnings came out today.
- Corbus Pharmaceuticals (NASDAQ:CRBP) stock moved upwards by 20.34% to $0.29. The market value of their outstanding shares is at $35.7 million. As per the news, the Q1 earnings report came out yesterday.
- ClearPoint Neuro (NASDAQ:CLPT) shares rose 17.63% to $8.34. The company's market cap stands at $197.7 million. As per the news, the Q1 earnings report came out today.
- X4 Pharmaceuticals (NASDAQ:XFOR) shares increased by 14.28% to $1.2. The company's market cap stands at $36.9 million.
- Vaxxinity (NASDAQ:VAXX) stock moved upwards by 12.81% to $4.49. The company's market cap stands at $565.0 million. As per the news, the Q1 earnings report came out 2 days ago.
Losers
- Eargo (NASDAQ:EAR) stock fell 21.2% to $1.34 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 100.6K shares, which is 14.6 percent of its average volume over the last 100 days. The company's market cap stands at $52.6 million.
- Evaxion Biotech (NASDAQ:EVAX) shares fell 15.71% to $1.61. This security traded at a volume of 77.7K shares come close, making up 20.4% of its average volume over the last 100 days. The market value of their outstanding shares is at $37.3 million. The company's, Q1 earnings came out today.
- Spruce Biosciences (NASDAQ:SPRB) stock declined by 13.29% to $1.11. The market value of their outstanding shares is at $26.0 million.
- First Wave BioPharma (NASDAQ:FWBI) shares decreased by 11.27% to $0.3. The company's market cap stands at $5.0 million.
- Soligenix (NASDAQ:SNGX) shares decreased by 10.87% to $0.36. The market value of their outstanding shares is at $15.5 million.
- Pear Therapeutics (NASDAQ:PEAR) stock decreased by 10.39% to $3.45. This security traded at a volume of 55.5K shares come close, making up 21.3% of its average volume over the last 100 days. The company's market cap stands at $475.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
